Currently Enrolling Trials in Liver Transplantation
Clinical Trials - Transplantation - Liver
James Markman, MD, PhD , Massachusetts General Hospital , Boston, MA;
Sandy Feng, MD, PhD , University of California San Francisco , San Francisco, CA
LITTMUS is a clinical research study testing a new approach to achieve transplant tolerance using the liver transplant recipient’s own T regulatory cells (Tregs).
James Markmann, MD, PhD, Massachusettes General Hospital, Boston, MA
OPTIMAL is a clinical trial that will be investigating immunosuppression withdrawal in liver transplant recipients.